RU2017145301A3 - - Google Patents

Download PDF

Info

Publication number
RU2017145301A3
RU2017145301A3 RU2017145301A RU2017145301A RU2017145301A3 RU 2017145301 A3 RU2017145301 A3 RU 2017145301A3 RU 2017145301 A RU2017145301 A RU 2017145301A RU 2017145301 A RU2017145301 A RU 2017145301A RU 2017145301 A3 RU2017145301 A3 RU 2017145301A3
Authority
RU
Russia
Application number
RU2017145301A
Other languages
Russian (ru)
Other versions
RU2017145301A (ru
RU2732229C3 (ru
RU2732229C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/583,177 external-priority patent/US8058229B2/en
Application filed filed Critical
Publication of RU2017145301A publication Critical patent/RU2017145301A/ru
Publication of RU2017145301A3 publication Critical patent/RU2017145301A3/ru
Application granted granted Critical
Publication of RU2732229C2 publication Critical patent/RU2732229C2/ru
Publication of RU2732229C3 publication Critical patent/RU2732229C3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/11—Protein-serine/threonine kinases (2.7.11)
    • C12Y207/1103—Receptor protein serine/threonine kinase (2.7.11.30)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
RU2017145301A 2017-12-22 Комбинированное применение ловушек gdf и активаторов рецепторов эритропоэтина для повышения содержания эритроцитов RU2732229C3 (ru)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
USPCT/US2009/004659 2009-08-13
US12/583,177 US8058229B2 (en) 2008-08-14 2009-08-13 Method of increasing red blood cell levels or treating anemia in a patient
PCT/US2009/004659 WO2010019261A1 (en) 2008-08-14 2009-08-13 Use of gdf traps to increase red blood cell levels
US12/583,177 2009-08-13
US30590110P 2010-02-18 2010-02-18
US61/305,901 2010-02-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2016123808A Division RU2642302C1 (ru) 2009-08-13 2010-08-13 Комбинированное применение ловушек gdf и активаторов рецепторов эритропоэтина для повышения содержания эритроцитов

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2020127574A Division RU2814047C3 (ru) 2020-08-19 Комбинированное применение ловушек gdf и активаторов рецепторов эритропоэтина для повышения содержания эритроцитов

Publications (4)

Publication Number Publication Date
RU2017145301A RU2017145301A (ru) 2019-06-24
RU2017145301A3 true RU2017145301A3 (enExample) 2019-06-24
RU2732229C2 RU2732229C2 (ru) 2020-09-14
RU2732229C3 RU2732229C3 (ru) 2024-02-13

Family

ID=

Also Published As

Publication number Publication date
IL252046A0 (en) 2017-06-29
HK1224199A1 (zh) 2017-08-18
KR101882521B1 (ko) 2018-07-27
RU2017145301A (ru) 2019-06-24
CA2770822A1 (en) 2011-02-17
JP2018177816A (ja) 2018-11-15
KR20190111158A (ko) 2019-10-01
CA2770822C (en) 2020-03-24
IL218052A (en) 2017-05-29
CN105561295A (zh) 2016-05-11
IL252044A0 (en) 2017-06-29
RU2592670C2 (ru) 2016-07-27
CN113082194B (zh) 2025-03-18
RU2012109393A (ru) 2013-09-20
IL275851A (en) 2020-08-31
NZ623113A (en) 2015-10-30
IL287990B (en) 2022-07-01
KR20120054024A (ko) 2012-05-29
CN113082194A (zh) 2021-07-09
MX2019010341A (es) 2019-10-21
CN113171442B (zh) 2024-11-15
IL252044B (en) 2019-11-28
KR102170682B1 (ko) 2020-10-28
EP2464369A4 (en) 2013-07-17
CN113577291A (zh) 2021-11-02
CN105561295B (zh) 2020-03-20
AU2010282361A1 (en) 2012-03-15
IL252045A0 (en) 2017-06-29
EP3838919A1 (en) 2021-06-23
IL252045B (en) 2020-05-31
KR20200124322A (ko) 2020-11-02
BR112012003232A2 (pt) 2016-11-22
JP2016034981A (ja) 2016-03-17
ES2844123T3 (es) 2021-07-21
NZ598348A (en) 2014-05-30
AU2010282361B2 (en) 2015-03-19
WO2011020045A9 (en) 2011-06-03
MX2012001916A (es) 2012-05-22
CN105535938A (zh) 2016-05-04
CN105535938B (zh) 2022-04-26
BR122020019169B1 (pt) 2022-09-27
KR20230003452A (ko) 2023-01-05
RU2642302C1 (ru) 2018-01-24
CN105412908A (zh) 2016-03-23
IL275851B (en) 2021-12-01
CN105412908B (zh) 2021-08-24
IL252046B (en) 2020-07-30
EP3117829A1 (en) 2017-01-18
RU2020127574A (ru) 2022-02-21
RU2732229C2 (ru) 2020-09-14
KR102606494B1 (ko) 2023-11-24
NZ712943A (en) 2017-08-25
JP6860533B2 (ja) 2021-04-14
EP2464369B1 (en) 2020-03-11
JP2013501816A (ja) 2013-01-17
WO2011020045A1 (en) 2011-02-17
JP5909446B2 (ja) 2016-04-26
IL218052A0 (en) 2012-04-30
JP2020203953A (ja) 2020-12-24
IL287990A (en) 2022-01-01
KR20180085825A (ko) 2018-07-27
BR112012003232B1 (pt) 2022-02-22
CN102655872B (zh) 2016-01-20
ES2796121T3 (es) 2020-11-25
HK1223818A1 (zh) 2017-08-11
CN102655872A (zh) 2012-09-05
CN113171442A (zh) 2021-07-27
EP3117829B1 (en) 2020-10-07
EP2464369A1 (en) 2012-06-20

Similar Documents

Publication Publication Date Title
BE2015C040I2 (enExample)
BR112012008195A2 (enExample)
BRPI0924307A2 (enExample)
BR112012008267A2 (enExample)
BR112012012396A2 (enExample)
BR112012000607A2 (enExample)
BR112012000665A2 (enExample)
BR122021004633A2 (enExample)
BR112012012487A2 (enExample)
BR122017024704A2 (enExample)
BR112012003853A2 (enExample)
BR112012009797A2 (enExample)
BR112012009703A2 (enExample)
BR112012010357A2 (enExample)
BR112012001263A2 (enExample)
BR112012014856A2 (enExample)
BR112012000159A2 (enExample)
BR112012007654A2 (enExample)
BR112012007672A2 (enExample)
BR112012000156A2 (enExample)
BR112012007671A2 (enExample)
BR112012009404A2 (enExample)
BR122017013721A2 (enExample)
BRPI0924617A2 (enExample)
BRPI0925022A2 (enExample)